even though this is not kennedy s disease sbma related , the gene replacement therapy mentioned in the two articles shows another major step forward in this type of treatment if they can accomplish these type results for sma , the potential treatment for spinal bulbar muscular atrophy is a little closer the gene therapy animation is short , but nicely explained in this youtube video note information for parents of children with sma who want to learn more about study participation can visit studysmanow com the well written article explaining dr mendell s research in nationwide children s does a good job of explaining the treatment and where they are in the process phase replacement therapy article sma is a progressive , childhood , neuromuscular disease caused by a mutation in a single gene children with sma fail to meet motor milestones and typically die or require permanent mechanical ventilation by years of age the phase clinical trial is the first to test the functional replacement of the mutated gene responsible for sma a one time intravenous injection of modified adeno associated virus serotype aav delivered the smn gene to patients three patients received a low dose , while patients received a high dose in the phase trial , patients in the high dose group demonstrated improvement in motor function and they had a decreased need for supportive care compared to the natural history of the disease specifically , at the end of the study period , all patients appeared to have a favorable safety profile and to be generally well tolerated of the patients treated with the high dose , percent of patients have achieved head control , percent of patients can roll over and percent of patients can sit with assistance seventy five percent of these patients are now sitting for seconds or longer two patients can crawl , pull to stand and stand and walk independently according to natural history of the disease , patients require nutritional and respiratory support by months of age , and are not able to swallow or speak effectively of the patients who received the high dose in study , patients are able to speak , patients are fed orally and seven do not require bi level positive airway pressure as of the data cut off august ,